The alternative asset management arm of CLSA, Asia's leading independent brokerage and investment group
The alternative asset management arm of CLSA, Asia's leading independent brokerage and investment group
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Nov 11, 2022
F88
|
Debt Financing | $60M | Consumer | Yes |
|
Sep 26, 2018
ACT Genomics
|
Series C | — | Bioinformatics | Yes |
|
Jun 5, 2018
MyRepublic
|
Private Equity(PE) | $60M | Internet | Yes |